Risk of Plasmodium vivax parasitaemia after Plasmodium falciparum infection: a systematic review and meta-analysis (Q60923156)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30587297%20AND%20SRC:MED&resulttype=core&format=json

16 April 2020

meta-analysis

0 references

title

Risk of Plasmodium vivax parasitaemia after Plasmodium falciparum infection: a systematic review and meta-analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30587297%20AND%20SRC:MED&resulttype=core&format=json

16 April 2020

0 references

1 reference

Plasmodium falciparum

1 reference

1 reference

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30587297%20AND%20SRC:MED&resulttype=core&format=json

16 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30587297%20AND%20SRC:MED&resulttype=core&format=json

16 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30587297%20AND%20SRC:MED&resulttype=core&format=json

16 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30587297%20AND%20SRC:MED&resulttype=core&format=json

16 April 2020

Julie A Simpson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30587297%20AND%20SRC:MED&resulttype=core&format=json

16 April 2020

Kamala Thriemer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30587297%20AND%20SRC:MED&resulttype=core&format=json

16 April 2020

Mohammad S Hossain

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30587297%20AND%20SRC:MED&resulttype=core&format=json

16 April 2020

Georgina S Humphreys

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30587297%20AND%20SRC:MED&resulttype=core&format=json

16 April 2020

Carol H Sibley

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30587297%20AND%20SRC:MED&resulttype=core&format=json

16 April 2020

language of work or name

English

0 references

publication date

1 January 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30587297%20AND%20SRC:MED&resulttype=core&format=json

Lancet Infectious Diseases

16 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30587297%20AND%20SRC:MED&resulttype=core&format=json

16 April 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30587297%20AND%20SRC:MED&resulttype=core&format=json

16 April 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30587297%20AND%20SRC:MED&resulttype=core&format=json

16 April 2020

page(s)

91-101

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30587297%20AND%20SRC:MED&resulttype=core&format=json

Plasmodium vivax recurrence following falciparum and mixed species malaria: risk factors and effect of antimalarial kinetics

16 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930596-6

7 January 2021

High rate of Plasmodium vivax relapse following treatment of falciparum malaria in Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930596-6

7 January 2021

Chemotherapeutic strategies for reducing transmission of Plasmodium vivax malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930596-6

7 January 2021

Major burden of severe anemia from non-falciparum malaria species in Southern Papua: a hospital-based surveillance study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930596-6

7 January 2021

Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930596-6

7 January 2021

Artemisinin combination therapy for vivax malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930596-6

7 January 2021

A long neglected world malaria map: Plasmodium vivax endemicity in 2010

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930596-6

7 January 2021

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930596-6

7 January 2021

Geographical variation in Plasmodium vivax relapse

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930596-6

7 January 2021

The relationship between the haemoglobin concentration and the haematocrit in Plasmodium falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930596-6

7 January 2021

Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930596-6

7 January 2021

Transformations Related to the Angular and the Square Root

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930596-6

7 January 2021

Bias in meta-analysis detected by a simple, graphical test

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930596-6

7 January 2021

Conducting Meta-Analyses in R with the metafor Package

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930596-6

7 January 2021

Randomised comparative study of mefloquine, qinghaosu, and pyrimethamine-sulfadoxine in patients with falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930596-6

7 January 2021

A review of mixed malaria species infections in anopheline mosquitoes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930596-6

7 January 2021

The activation of vivax malaria hypnozoites by infectious diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930596-6

7 January 2021

Determinants of relapse periodicity in Plasmodium vivax malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930596-6

7 January 2021

Comparison of artemether-lumefantrine and chloroquine with and without primaquine for the treatment of Plasmodium vivax infection in Ethiopia: A randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930596-6

7 January 2021

Comparison of the Cumulative Efficacy and Safety of Chloroquine, Artesunate, and Chloroquine-Primaquine in Plasmodium vivax Malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930596-6

7 January 2021

Pharmacokinetics and pharmacodynamics of lumefantrine (benflumetol) in acute falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930596-6

7 January 2021

Population Pharmacokinetic Properties of Piperaquine in Falciparum Malaria: An Individual Participant Data Meta-Analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930596-6

7 January 2021

Population pharmacokinetics of orally administered mefloquine in healthy volunteers and patients with uncomplicated Plasmodium falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930596-6

7 January 2021

A trial of combination antimalarial therapies in children from Papua New Guinea.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930596-6

7 January 2021

Blood stage antimalarial efficacy of primaquine in Plasmodium vivax malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930596-6

7 January 2021

Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930596-6

7 January 2021

Primaquine toxicity forestalls effective therapeutic management of the endemic malarias

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930596-6

7 January 2021

Tafenoquine receives regulatory approval in U.S. for prophylaxis of malaria and radical cure of Plasmodium vivax

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930596-6

7 January 2021

Mortality attributable to Plasmodium vivax malaria: a clinical audit from Papua, Indonesia

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/30587297

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1016/S1473-3099(18)30596-6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30587297%20AND%20SRC:MED&resulttype=core&format=json

16 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30587297%20AND%20SRC:MED&resulttype=core&format=json

16 April 2020

PubMed publication ID

30587297

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30587297%20AND%20SRC:MED&resulttype=core&format=json